Designing effective precision medicine studies requires more than scientific insight, it demands foresight. For one sponsor, an Alzheimer’s disease study missed its primary endpoint, prompting an urgent need to understand how trial success could be improved.

Using KerusCloud®, MMS transformed a failed retrospective analysis into a data-driven proof of concept, demonstrating how simulation-guided design can dramatically increase study success and accelerate precision medicine programs.

This case study reveals how sponsors can de-risk development, rescue high-value programs, and optimize clinical trial outcomes through smarter, simulation-powered design strategies.

Drive Precision Medicine Success with KerusCloud® Simulation Design

Download your free Case Study today ↓

Key Benefits / What You’ll Learn:

• Evaluate “what-if” scenarios to predict trial outcomes before enrollment begins.
• Increase probability of success (PoS) by up to 44% through simulation-guided design.
• Identify key drivers of trial success using synthetic patient populations and real-world data.
• Integrate pharmacogenetics (PGx) from the start for more meaningful, precision-driven insights.
• Reduce development time and cost while improving patient targeting and study efficiency.

Developed and validated by MMS biostatistics and simulation experts, KerusCloud® has supported precision medicine research published in Drug Discovery Today and Preventive & Predictive Genetics.